Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160026/S076

LIFEPAK 35 monitor/defibrillator

Physio-Control, Inc. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP160026/S076

What did the FDA decide?

The FDA record shows a 30-day notice for P160026/S076, a supplement to the LIFEPAK® 35 monitor/defibrillator PMA held by Physio-Control, Inc. The listed change is a supplier manufacturing process change tied to the high energy storage capacitor. The device category is automated external defibrillators (non-wearable), product code MKJ, specialty Cardiovascular. The supplement number, not a standalone filing, ties this notice to the original P160026 approval; the decision does not approve the whole system anew.

The database gives the decision as OK30 and the supplement reason as a manufacturer, sterilizer, packager or supplier process change. The record does not identify the supplier, describe the prior or revised capacitor process, or state whether capacitor performance specifications changed. The statement of purpose is a regulatory filing description, not independent evidence of safety or clinical effectiveness, and no clinical or performance data are supplied here.

FDA approval order statement

a supplier manufacturing process change associated with the high energy storage capacitor
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160026/S076
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
OK30
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160026. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160026 · Original PMA

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  2. P160026/S069 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  3. P160026/S073 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  4. P160026/S074 · Related supplement

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  5. P160026/S076 received

    Application receipt date recorded by FDA.

  6. P160026/S076 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160026

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records